{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"autoimmune-lymphoproliferative-syndrome-type-2a","columns":[{"gene":"","key":"population-3f0fbb5dad2c19fb4437","label":"Autoimmune lymphoproliferative syndrome, type IIA","mondoId":"MONDO:0011383","onsetQualifier":null,"originColumnKey":"MONDO:0011383/OMIM:603909","originalViews":[{"key":"MONDO:0011383/OMIM:603909","label":"Autoimmune lymphoproliferative syndrome, type IIA","scopeLabel":"OMIM:603909","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["18ab53012f77b9ee7b50c4c37bbdcf81077e6334d9fe78159f0b5ca62c8633bc","2059a504f97d2bcc9b58e26c51f0a9252c67e806de52f5b042f63161f70d5d5e","337aabc329671aae888747d8557dabfe057b85a2128d67d3a90e7f0c94b498aa","33870dfe941ea07e51e303acaf2907821f750d0ea83ab3c56ed9e9e588988176","371e84a6313cc36d1dab2d937a6ee71494c5d07bcc0e5871e83017e92241ef53","39ab07e658b0ab2e7b7c997d170b61778f3f283685723a67b8fdf2e324dc0f70","48c60799eebe91c4813acefe14ae511c1dd6ee186f908260f547e7a69cf57cfb","4ac19a336c4c21bcc3a328f670616799837b9c2353f3655632e12f0569dc0c3d","58235544797f52ad06a584370a5a98db4e85a021f71acd59617d84d26d7e0e46","69a5d62c7e7cf1da73f365150adb081dffaf3bcf02ce85f4c429e4a1c283a167","6fe4e8bf0dc3bc32fc0e17bcdd2a4ede7c7cc7dd42e07110304dde465ca497e2","76b357313c47a3ef33825601d2b50358201ce93aafcf71bafb737a569bc457be","7930d8cb2b9415b28f9124771d7bca73fd1bcb921b92c706f2ea2bdab6db4c15","80e627f7e73960957ff58a3e3815ec88fba9c3519fdeab9324341884e29bd514","86bda9aa12581f4df52033bc464de4e3ab78aa8c588209dead4adaa2aa61114e","952f85c9d0a5489fd33618cfc2cb62347a2c3ba3c9ed45b139ce9e9c2e2175ac","a5a9f220c78d0b53b0d7beeb2baf02002c70e4f0477013d65445afd7995450b3","aed6d19c90d02abc6bd7b9fed89f8374fe964fc4de898e0bbd6608f15d8cad00","b031bbdc80f211eca50dd03ea213bbb1ad8b2bd9b76c7020441d143d1b2a5bb8","b28122c19324932875d22a435e01ac49a29c4e31c8f3c493e7915b7c2ff5bcf6","c30662507ebaa159f672ee5a54c7133635238049f209d211957e3a37242f5904","c324cb6ee2869f57e044e277457ed426af09d4e7bce2989ccf65cd5004c406b9","c456742a193ebeb62c3d338056a6c7c139efb1488c6ac572a3c64490278fc5cd","c45ad65efe0082273fe577d25dbcf69fb3ed8e8898e5e1718cd90d896ae90a50","c96956a7864350b3b82d9ed8a188bc77b3ad94d3832c8190ea034fd8e89515e1","cff447a034aef91d532a4de543219bb082862c4f45a0a757895ca8f699bccd56","d57c54eb8947dabc294a8ea85d61c239184d2fc22aeddafc3523179219bac035","e00dc0396f8986858a31224aa3753186e28c9332c05ae479097407507e326f17","e1b47560375cd1a3a0b7676bfb37bf16268b3b0700a49c9fc7ed87841ab6fe4a","e27978a208c9594346b35a5498bc6864721f45d266ea49d18d4f7f65fe697175","e35ae923f00cd25f33e4ceaef3dd84fd27ab1064e6e6ba0f003c777145fb56a5","e50c2b261e50c01234619853a5c4d3927374cb8582542e7b9755d909f2ecd206","f17f693fbf594e5c8a3f50110f2df3bda25d931e53d55e5bf3653d2d65e7e823","ff1309533b2019fa7818e13e789fe3759fe0708b978c786162a6d46d613ea6b9"],"recordQualifiers":{},"scopeLabel":"OMIM:603909","sourceIds":["OMIM:603909"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-3f0fbb5dad2c19fb4437"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003262","HP:0003453","HP:0003493","HP:0003613","HP:0001890","HP:0001904","HP:0001973"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":8,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":34,"sourceGroups":{"omim":21,"published":13}},"features":[{"hpoId":"HP:0003262","label":"Anti-smooth muscle antibody positivity","primary":true},{"hpoId":"HP:0003453","label":"Antineutrophil antibody positivity","primary":true},{"hpoId":"HP:0003493","label":"Antinuclear antibody positivity","primary":true},{"hpoId":"HP:0003613","label":"Antiphospholipid antibody positivity","primary":true},{"hpoId":"HP:0001890","label":"Autoimmune hemolytic anemia","primary":true},{"hpoId":"HP:0001904","label":"Autoimmune neutropenia","primary":true},{"hpoId":"HP:0001973","label":"Autoimmune thrombocytopenia","primary":true},{"hpoId":"HP:0002730","label":"Chronic noninfectious lymphadenopathy","primary":false},{"hpoId":"HP:0004844","label":"Coombs-positive hemolytic anemia","primary":false},{"hpoId":"HP:0002731","label":"Decreased T cell apoptosis","primary":false},{"hpoId":"HP:0003565","label":"Elevated erythrocyte sedimentation rate","primary":false},{"hpoId":"HP:0002729","label":"Follicular hyperplasia","primary":false},{"hpoId":"HP:0002239","label":"Gastrointestinal hemorrhage","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0003261","label":"Increased circulating IgA concentration","primary":false},{"hpoId":"HP:0003237","label":"Increased circulating IgG concentration","primary":false},{"hpoId":"HP:0003496","label":"Increased circulating IgM concentration","primary":false},{"hpoId":"HP:0002851","label":"Increased double-negative T cell number","primary":false},{"hpoId":"HP:0002853","label":"Increased HLA-DR+ CD4+ T cell proportion","primary":false},{"hpoId":"HP:0005404","label":"Increased total B cell count","primary":false},{"hpoId":"HP:0001880","label":"Increased total eosinophil count","primary":false},{"hpoId":"HP:0001891","label":"Iron deficiency anemia","primary":false},{"hpoId":"HP:0002716","label":"Lymphadenopathy","primary":false},{"hpoId":"HP:0025300","label":"Malar rash","primary":false},{"hpoId":"HP:0000123","label":"Nephritis","primary":false},{"hpoId":"HP:0000100","label":"Nephrotic syndrome","primary":false},{"hpoId":"HP:0000967","label":"Petechiae","primary":false},{"hpoId":"HP:0003454","label":"Platelet antibody positive","primary":false},{"hpoId":"HP:0002972","label":"Reduced delayed hypersensitivity","primary":false},{"hpoId":"HP:0002923","label":"Rheumatoid factor positive","primary":false},{"hpoId":"HP:0001744","label":"Splenomegaly","primary":false},{"hpoId":"HP:0001873","label":"Thrombocytopenia","primary":false},{"hpoId":"HP:0001025","label":"Urticaria","primary":false},{"hpoId":"HP:0002633","label":"Vasculitis","primary":false}],"ledeHtml":"A rare, primary immunodeficiency with an autosomal dominant pattern of inheritance but incomplete penetrance. It is caused by a mutation in the CASP10 (caspase-10) gene that leads to defective Fas-induced apoptosis. Disruption of Fas-induced apoptosis impairs lymphocyte homeostasis and immune tolerance. Characteristic laboratory findings include an increase in circulating, double-negative (CD4-/CD8-) T cells in the setting of immune-mediated anemia, thrombocytopenia and neutropenia. Clinical signs present in childhood include fatigue, pallor, bruising, hepatosplenomegaly and chronic, non-malignant, non-infectious lymphadenopathy. The clinical course is influenced by a strong association with other autoimmune disorders and an increased risk for developing Hodgkin and non-Hodgkin lymphoma.","mondoId":"MONDO:0011383","node":{"canonicalSlug":"autoimmune-lymphoproliferative-syndrome-type-2a","comparisons":[{"documentSha256":"b24598e5e8ef9fb461e0589c499ee1d42343699ab60d2a8e72eb2bdc05b0f269","key":"legacy-autoimmune-lymphoproliferative","kind":"legacy","label":"autoimmune lymphoproliferative syndrome","memberIds":["MONDO:0011158","MONDO:0011383","MONDO:0011804","MONDO:0013767","MONDO:0014493","MONDO:0017979","MONDO:8000024"],"mondoId":"MONDO:0017979","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/autoimmune-lymphoproliferative.b24598e5e8ef9fb461e0589c499ee1d42343699ab60d2a8e72eb2bdc05b0f269.json"},{"documentSha256":"2a8dea17ad3684543a532636b1570fe11ac8e4f110741a3c752dca9ca9c3d80a","key":"expanded-autoimmune-lymphoproliferative","kind":"expanded","label":"autoimmune lymphoproliferative syndrome","memberIds":["MONDO:0011158","MONDO:0011383","MONDO:0011804","MONDO:0013767","MONDO:0014493","MONDO:0017979","MONDO:0018702","MONDO:1060194","MONDO:8000023","MONDO:8000024"],"mondoId":"MONDO:0017979","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-2a8dea17ad3684543a53.2a8dea17ad3684543a532636b1570fe11ac8e4f110741a3c752dca9ca9c3d80a.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"autoimmune lymphoproliferative syndrome type 2A","paragraphs":["A rare, primary immunodeficiency with an autosomal dominant pattern of inheritance but incomplete penetrance. It is caused by a mutation in the CASP10 (caspase-10) gene that leads to defective Fas-induced apoptosis. Disruption of Fas-induced apoptosis impairs lymphocyte homeostasis and immune tolerance. Characteristic laboratory findings include an increase in circulating, double-negative (CD4-/CD8-) T cells in the setting of immune-mediated anemia, thrombocytopenia and neutropenia. Clinical signs present in childhood include fatigue, pallor, bruising, hepatosplenomegaly and chronic, non-malignant, non-infectious lymphadenopathy. The clinical course is influenced by a strong association with other autoimmune disorders and an increased risk for developing Hodgkin and non-Hodgkin lymphoma."],"scope":"exact","source":"MONDO","upstream":"NCIT:C39576","url":"https://monarchinitiative.org/MONDO:0011383"},"ownColumnKeys":["population-3f0fbb5dad2c19fb4437"],"publication":"published","relationships":[{"kind":"parent","label":"autoimmune lymphoproliferative syndrome","mondoId":"MONDO:0017979","slug":"autoimmune-lymphoproliferative"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/15361"}],"translation":"published"},"records":[{"frequencyKind":"count","key":"18ab53012f77b9ee7b50c4c37bbdcf81077e6334d9fe78159f0b5ca62c8633bc","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002716","is_excluded":false,"label":"Lymphadenopathy","onset_id":"HP:0003593","reference":"PMID:10412980","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"2059a504f97d2bcc9b58e26c51f0a9252c67e806de52f5b042f63161f70d5d5e","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001873","is_excluded":false,"label":"Thrombocytopenia","onset_id":null,"reference":"PMID:16446975","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"337aabc329671aae888747d8557dabfe057b85a2128d67d3a90e7f0c94b498aa","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001880","is_excluded":false,"label":"Increased total eosinophil count","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"33870dfe941ea07e51e303acaf2907821f750d0ea83ab3c56ed9e9e588988176","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"PCS","frequency_raw":"20/20","hpo_id":"HP:0004844","is_excluded":false,"label":"Coombs-positive hemolytic anemia","onset_id":null,"reference":"OMIM:603909;PMID:16446975","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"371e84a6313cc36d1dab2d937a6ee71494c5d07bcc0e5871e83017e92241ef53","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002923","is_excluded":false,"label":"Rheumatoid factor positive","onset_id":null,"reference":"PMID:10412980","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"39ab07e658b0ab2e7b7c997d170b61778f3f283685723a67b8fdf2e324dc0f70","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002972","is_excluded":false,"label":"Reduced delayed hypersensitivity","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"48c60799eebe91c4813acefe14ae511c1dd6ee186f908260f547e7a69cf57cfb","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002730","is_excluded":false,"label":"Chronic noninfectious lymphadenopathy","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"4ac19a336c4c21bcc3a328f670616799837b9c2353f3655632e12f0569dc0c3d","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003613","is_excluded":false,"label":"Antiphospholipid antibody positivity","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"58235544797f52ad06a584370a5a98db4e85a021f71acd59617d84d26d7e0e46","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001025","is_excluded":false,"label":"Urticaria","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"69a5d62c7e7cf1da73f365150adb081dffaf3bcf02ce85f4c429e4a1c283a167","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0005404","is_excluded":false,"label":"Increased total B cell count","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"6fe4e8bf0dc3bc32fc0e17bcdd2a4ede7c7cc7dd42e07110304dde465ca497e2","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0003565","is_excluded":false,"label":"Elevated erythrocyte sedimentation rate","onset_id":null,"reference":"PMID:10412980","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"76b357313c47a3ef33825601d2b50358201ce93aafcf71bafb737a569bc457be","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003261","is_excluded":false,"label":"Increased circulating IgA concentration","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"7930d8cb2b9415b28f9124771d7bca73fd1bcb921b92c706f2ea2bdab6db4c15","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002239","is_excluded":false,"label":"Gastrointestinal hemorrhage","onset_id":null,"reference":"PMID:16446975","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"80e627f7e73960957ff58a3e3815ec88fba9c3519fdeab9324341884e29bd514","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001891","is_excluded":false,"label":"Iron deficiency anemia","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"86bda9aa12581f4df52033bc464de4e3ab78aa8c588209dead4adaa2aa61114e","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002633","is_excluded":false,"label":"Vasculitis","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"952f85c9d0a5489fd33618cfc2cb62347a2c3ba3c9ed45b139ce9e9c2e2175ac","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000100","is_excluded":false,"label":"Nephrotic syndrome","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a5a9f220c78d0b53b0d7beeb2baf02002c70e4f0477013d65445afd7995450b3","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002853","is_excluded":false,"label":"Increased HLA-DR+ CD4+ T cell proportion","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"aed6d19c90d02abc6bd7b9fed89f8374fe964fc4de898e0bbd6608f15d8cad00","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001904","is_excluded":false,"label":"Autoimmune neutropenia","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"b031bbdc80f211eca50dd03ea213bbb1ad8b2bd9b76c7020441d143d1b2a5bb8","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"PMID:10412980","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"b28122c19324932875d22a435e01ac49a29c4e31c8f3c493e7915b7c2ff5bcf6","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002729","is_excluded":false,"label":"Follicular hyperplasia","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c30662507ebaa159f672ee5a54c7133635238049f209d211957e3a37242f5904","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000123","is_excluded":false,"label":"Nephritis","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"c324cb6ee2869f57e044e277457ed426af09d4e7bce2989ccf65cd5004c406b9","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001890","is_excluded":false,"label":"Autoimmune hemolytic anemia","onset_id":null,"reference":"PMID:10412980","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c456742a193ebeb62c3d338056a6c7c139efb1488c6ac572a3c64490278fc5cd","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"PMID:10412980","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c45ad65efe0082273fe577d25dbcf69fb3ed8e8898e5e1718cd90d896ae90a50","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002851","is_excluded":false,"label":"Increased double-negative T cell number","onset_id":null,"reference":"PMID:10412980","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c96956a7864350b3b82d9ed8a188bc77b3ad94d3832c8190ea034fd8e89515e1","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003453","is_excluded":false,"label":"Antineutrophil antibody positivity","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"cff447a034aef91d532a4de543219bb082862c4f45a0a757895ca8f699bccd56","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0025300","is_excluded":false,"label":"Malar rash","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"d57c54eb8947dabc294a8ea85d61c239184d2fc22aeddafc3523179219bac035","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003496","is_excluded":false,"label":"Increased circulating IgM concentration","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e00dc0396f8986858a31224aa3753186e28c9332c05ae479097407507e326f17","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003493","is_excluded":false,"label":"Antinuclear antibody positivity","onset_id":null,"reference":"PMID:16446975","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"e1b47560375cd1a3a0b7676bfb37bf16268b3b0700a49c9fc7ed87841ab6fe4a","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003237","is_excluded":false,"label":"Increased circulating IgG concentration","onset_id":null,"reference":"PMID:16446975","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"e27978a208c9594346b35a5498bc6864721f45d266ea49d18d4f7f65fe697175","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003262","is_excluded":false,"label":"Anti-smooth muscle antibody positivity","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e35ae923f00cd25f33e4ceaef3dd84fd27ab1064e6e6ba0f003c777145fb56a5","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002731","is_excluded":false,"label":"Decreased T cell apoptosis","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e50c2b261e50c01234619853a5c4d3927374cb8582542e7b9755d909f2ecd206","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001973","is_excluded":false,"label":"Autoimmune thrombocytopenia","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f17f693fbf594e5c8a3f50110f2df3bda25d931e53d55e5bf3653d2d65e7e823","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000967","is_excluded":false,"label":"Petechiae","onset_id":null,"reference":"PMID:16446975","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"ff1309533b2019fa7818e13e789fe3759fe0708b978c786162a6d46d613ea6b9","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:603909","disease_name":"Autoimmune lymphoproliferative syndrome, type IIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003454","is_excluded":false,"label":"Platelet antibody positive","onset_id":null,"reference":"OMIM:603909","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011383\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>NCIT:C39576</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare, primary immunodeficiency with an autosomal dominant pattern of inheritance but incomplete penetrance. It is caused by a mutation in the CASP10 (caspase-10) gene that leads to defective Fas-induced apoptosis. Disruption of Fas-induced apoptosis impairs lymphocyte homeostasis and immune tolerance. Characteristic laboratory findings include an increase in circulating, double-negative (CD4-/CD8-) T cells in the setting of immune-mediated anemia, thrombocytopenia and neutropenia. Clinical signs present in childhood include fatigue, pallor, bruising, hepatosplenomegaly and chronic, non-malignant, non-infectious lymphadenopathy. The clinical course is influenced by a strong association with other autoimmune disorders and an increased risk for developing Hodgkin and non-Hodgkin lymphoma.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011383\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"autoimmune-lymphoproliferative-syndrome-type-2a","sourceDocuments":[{"name":"MONDO: autoimmune lymphoproliferative syndrome type 2A","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011383"}],"sourceNote":"","synonyms":["ALPS-CASP10","ALPS2A","autoimmune lymphoproliferative syndrome caused by mutation in CASP10","autoimmune lymphoproliferative syndrome, type II","autoimmune lymphoproliferative syndrome, type IIA","autoimmune lymphoproliferative syndrome-CASP10 variant","CASP10 autoimmune lymphoproliferative syndrome","type 2 ALPS","type 2 autoimmune lymphoproliferative syndrome"],"takeawayHtml":"","title":"autoimmune lymphoproliferative syndrome type 2A"},"schemaVersion":1}
